Orchestra BioMed Holdings, Inc. insider David Pacitti buys $100,000 in OBIO shares
The purchase raises the insider's holding by 37%, the filing shows. Information only, not investment advice.
A Form 4 filed on Nov 9 shows David Pacitti (Director) purchasing 20,000 Orchestra BioMed Holdings, Inc. shares worth about $100,000 on Nov 9.
The purchase was made in the open market, not through an award, an option exercise or a plan. After the trade, the filing lists 74,750 shares held.
The trade was reported within two business days, as Section 16 requires. Other Orchestra BioMed Holdings, Inc. insiders have also bought: Four insiders made open-market purchases within 14 days, a pattern known as a cluster buy.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Orchestra BioMed Holdings, Inc. (OBIO) |
|---|---|
| Insider | David Pacitti |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 20,000 |
| Average price | $5.00 |
| Value | $100,000 |
| Trade date | Nov 9, 2026 |
| Filed with the SEC | Nov 9, 2026, 4:31 PM ET |
| Shares held after | 74,750 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
See all the latest insider trades · See the latest cluster buys and sells
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.